AUSTRALIAN ADVENT PHARMACEUTICALS PTY LTD
-
Aurobindo to acquire under development product, related assets from Advent for $12.5mn
The indicative time period for completion of the acquisition is January 2019, Aurobindo Pharma said.
Advertisement
Advertisement